The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function.

Source:http://linkedlifedata.com/resource/pubmed/id/18485086

Download in:

View as

General Info

PMID
18485086